SUBJECT: AFFIRMATIVE ACTION AND EQUAL EMPLOYMENT OPPORTUNITY POLICY
APPLIES TO: All Employees and Applicants for Employment
DATE: June 1, 2024
Mapp Biopharmaceutical, Inc. (hereinafter “Company”) has an enduring commitment to the concept and
practice of equal employment opportunity and affirmative action as well as to affirming the value of
diversity and promoting a workplace free from discrimination.
It is the policy of the Company to provide equal employment opportunities without regard to race, color,
religion, sex, sexual orientation, gender identity or expression, national origin, genetic information, age,
disability, marital starus, veteran status, or a person’s relationship or association with a protected veteran,
including spouses and other famjly members or any other protected characteristic under applicable law.
This policy relates to all aspects of employment, including recruitment, selection, job assignment, training,
compensation, benefits, discipline, promotion, transfer, the use of facilities, participation in all company-sponsored
employee activities, layoff, and termination processes. Provisions in applicable laws providing
for bona fide occupational qualifications, business necessity or age limitations will be adhered to by the
company where appropriate. Regular review helps ensure compliance with this policy.
The Company has developed and maintained a written Affirmative Action Program (AAP). The Company
maintains an audit and reporting system to determine overall compliance with its equal employment
opportunity mandates. I have delegated overall responsibility oftbe AAP to the Affirmative Action Officer,
Kenneth G. Payie, PhD, Chief Operating Officer. Kenneth G. Payie, PhD oversees the affirmative action
plan development, modification, implementation, effectiveness, reporting requirements and conducts
management updates. The Company invites any applicant and/or employee to review the Company’s
written Affirmative Action Plan. This plan is available for inspection during normal business hours. Please
request an appointment by contacting Kenneth G. Payie, PhD at 858-224-9669.
The Company will ensure that employees and applicants shall not be subjected to harassment due to their
status described above, or any harassment, intimidation, threats, coercion or discrimination because they
have engaged in or may engage in any of the following activities; ( 1) filing a complaint with the Company
or with federal, state, or local agencies regarding starus covered under this AAP, (2) assisting or
participating in any investigation, compliance review, hearing, or any other activity related to the
administration of any federal, state, or local equal employment opportunity or affirmative action statute
pertaining to the starus covered under this AAP; (3) opposing any act or practice made unlawful by section
503 and/or VEVRAA, and (4) exercising any other right protected by section 503 and/or VEVRAA or its
implementing regulations in this part. Concerns and complaints related to equal opportunity based on
aspects of diversity protected under federal, state, and local law, including sexual harassment complaints
should be directed to the attention of Kenneth G. Payie, PhD at 858-224-9669.
As Chief Executive Officer of Mapp Biopharmaceutical, Inc., I fully support our affirmative action program
and am committed to the implementation of the company’s equal opportunity and affirmative action
policies. I urge each employee to commit to carrying out the intent of these policies. Specifically, it is the
responsibility of each supervisor to ensure the implementation of these policies to avoid any discrimination
in employment. Violation of these policies is a disciplinary offense.
